[EN] TYK2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE TYK2 ET LEURS UTILISATIONS
申请人:NIMBUS LAKSHMI INC
公开号:WO2018075937A1
公开(公告)日:2018-04-26
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
本发明提供了化合物、其组合物以及使用这些化合物来抑制TYK2并治疗TYK2介导的疾病的方法。
Two enantiocomplementary Baeyer-Villiger monooxygenases newly identified for asymmetric oxyfunctionalization of thioether
作者:Shiyu Wei、Yafei Liu、Jieyu Zhou、Guochao Xu、Ye Ni
DOI:10.1016/j.mcat.2021.111784
日期:2021.8
efficiency toward thioanisole than cyclohexanone. As much as 50 mM thioanisole could be completely oxidized by AmBVMO and RaBVMO with 99% (R) and 95% (S), respectively. Molecular docking analysis further provides evidence for the complementary enantioselectivity of RaBVMO and AmBVMO. Our results demonstrate the potential application of the two novel BVMOs in asymmetric synthesis of sulfoxides.
Here we report a methionine sulfoxide reductase A (MsrA) homologue with extremely high substrate tolerance and a wide substrate scope for the biocatalytic preparation of enantiopure sulfoxides. This MsrA homologue which was obtained from Pseudomonas alcaliphila (named paMsrA) showed good activity and enantioselectivity towards a series of aryl methyl/ethyl sulfoxides 1a–1k, with electron-withdrawing
在这里,我们报告甲硫氨酸亚砜还原酶A(MsrA)同源物具有极高的底物耐受性和广泛的底物范围,用于对映纯亚砜的生物催化制备。从嗜碱假单胞菌获得的这种MsrA同源物(命名为pa MsrA)对一系列芳基甲基/乙基亚砜1a-1k具有良好的活性和对映选择性,在芳环上有吸电子或供电子取代基。通过重组PA催化的外消旋亚砜的不对称还原拆分,可以制备出R构型的手性亚砜,其收率约为50%,对映体过量高达99%。MsrA蛋白。更重要的是,在高达320 mM(约45 g L -1)的初始底物浓度下,以高对映选择性(E > 200)成功完成了动力学拆分,这代表了生物催化制备中底物浓度方面的巨大改进手性亚砜。
TYK2 inhibitors and uses thereof
申请人:Nimbus Lakshmi, Inc.
公开号:US10647713B2
公开(公告)日:2020-05-12
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
本发明提供了用于抑制 TYK2 和治疗 TYK2 介导的疾病的化合物、其组合物和使用方法。
TYK2 INHIBITORS AND USES THEREOF
申请人:Nimbus Lakshmi, Inc.
公开号:US20180134700A1
公开(公告)日:2018-05-17
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.